Featured Research

from universities, journals, and other organizations

Bathing abdomen in chemotherapy gives ovarian cancer patients better chance of survival

Date:
March 9, 2013
Source:
Society of Gynecologic Oncology
Summary:
A recent study suggests that patients with advanced ovarian cancer who undergo intensive treatment with chemotherapy that bathes the abdomen are significantly more likely to live longer than those who receive standard intravenous (IV) chemotherapy.

Patients with advanced ovarian cancer who undergo intensive treatment with chemotherapy that bathes the abdomen are significantly more likely to live longer than those who receive standard intravenous (IV) chemotherapy, according to a study that analyzed long-term follow-up from two landmark Gynecologic Oncology Group (GOG) trials comprising 876 patients.

Results of the study are being presented at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer in Los Angeles, March 9-12.

Women who receive the treatment in the form of intraperitoneal, or IP chemotherapy are 17 percent more likely to survive longer than those who have IV chemotherapy, according to the analysis, which had a median follow-up of more than 10 years. Median survival was more than five years (62 months) for patients in the IP group and about four years (51 months) for patients in the IV group. Median is defined as the number separating the upper and lower half of a study population.

The findings also suggest women who complete most or all of the recommended six cycles of IP therapy are likely to live longer than women who complete four or fewer cycles. After five years, 59 percent of patients who completed five or six cycles of IP therapy were alive, compared to 33 percent of those who completed three or four cycles and 18 percent of those who completed one or two cycles. Patients who are unable to receive the full six cycles of IP therapy typically transition to IV chemotherapy for the remaining cycles.

"Too many women do not receive an explanation about the advantages and disadvantages of IP therapy and that it could be a potential life saver," said Devansu Tewari, MD, Director of Gynecologic Oncology for the Southern California Permanente Medical Group in Orange County, Calif., of Kaiser Permanente and Assistant Professor of Obstetrics and Gynecology at the University of California, Irvine School of Medicine. "But there is also a caution that it should be administered by a physician who has expertise in the treatment and can best manage the risks and side effects."

Every year, more than 22,000 women are diagnosed with ovarian cancer and more than 15,000 die of the disease. In standard IV chemotherapy, the drugs are infused into the bloodstream and throughout the body, whereas IP treatment directs the chemotherapy to the abdomen. This not only places a high concentration of cancer-killing drugs where they are needed, but the chemotherapy agents are absorbed more slowly, providing more exposure to the medicine. IP is recommended by the National Cancer Institute for women who have had optimal surgery.

Because IP therapy is more rigorous, some of the side effects are also more intense, such as numbness in the hands and feet and abdominal pain, and some women are unable to complete the suggested six cycles of therapy. Researchers found younger, healthier patients were more likely to complete more cycles of IP.

Funded by the National Cancer Institute, the Gynecologic Oncology Group comprises experts in the field, from gynecologic oncologists to nurses to scientists, who are committed to maintaining the highest standards in clinical trials. The GOG focuses its research on women with pelvic malignancies, such as cancer of the ovary, uterus and cervix.

"There is no question IP therapy should be much more widely offered, and advanced ovarian cancer patients should consult with gynecologic oncologists or medical oncologists with experience in this cancer who have the expertise to determine the best therapy," said Dr. Tewari. "At the very least, these women should be treated by someone who has experience with IP therapy issues and knowledge of whether she would be a good candidate."


Story Source:

The above story is based on materials provided by Society of Gynecologic Oncology. Note: Materials may be edited for content and length.


Cite This Page:

Society of Gynecologic Oncology. "Bathing abdomen in chemotherapy gives ovarian cancer patients better chance of survival." ScienceDaily. ScienceDaily, 9 March 2013. <www.sciencedaily.com/releases/2013/03/130309154959.htm>.
Society of Gynecologic Oncology. (2013, March 9). Bathing abdomen in chemotherapy gives ovarian cancer patients better chance of survival. ScienceDaily. Retrieved September 3, 2014 from www.sciencedaily.com/releases/2013/03/130309154959.htm
Society of Gynecologic Oncology. "Bathing abdomen in chemotherapy gives ovarian cancer patients better chance of survival." ScienceDaily. www.sciencedaily.com/releases/2013/03/130309154959.htm (accessed September 3, 2014).

Share This



More Health & Medicine News

Wednesday, September 3, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Snack Attack: Study Says Action Movies Make You Snack More

Snack Attack: Study Says Action Movies Make You Snack More

Newsy (Sep. 2, 2014) You're more likely to gain weight while watching action flicks than you are watching other types of programming, says a new study published in JAMA. Video provided by Newsy
Powered by NewsLook.com
U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

Newsy (Sep. 2, 2014) The U.N. says the problem is two-fold — quarantine zones and travel restrictions are limiting the movement of both people and food. Video provided by Newsy
Powered by NewsLook.com
Doctors Fear They're Losing Battle Against Ebola

Doctors Fear They're Losing Battle Against Ebola

AP (Sep. 2, 2014) As a third American missionary is confirmed to have contracted Ebola in Liberia, doctors on the ground in West Africa fear they're losing the battle against the outbreak. (Sept. 2) Video provided by AP
Powered by NewsLook.com
Tech Giants Bet on 3D Headsets for Gaming, Healthcare

Tech Giants Bet on 3D Headsets for Gaming, Healthcare

AFP (Sep. 2, 2014) When Facebook acquired the virtual reality hardware developer Oculus VR in March for $2 billion, CEO Mark Zuckerberg hailed the firm's technology as "a new communication platform." Duration: 02:24 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins